Skip to main content

Aurinia Pharmaceuticals (AUPH) Close To End Consolidation If Breaks Above USD 6.2

Aurinia Pharmaceuticals (AUPH) stock price appears to be ending an 18-month long consolidation phase since its March 2017 peak. The volatility is compressed and the price is dynamically supported above USD 5.5. If it breaks the USD 6.2 level it is expected to rally in direction of the previous price peak at USD 7.51 and should eventually take it out.  Shorter term there is a USD 5.95 resistance level that – if taken out – will provide the initial boost towards the next major resistance level 15 cents higher.

No Comments Yet

Leave a Reply

Your email address will not be published. Required fields are marked * logo

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: